Q&A with Ryan Heffner following INTERPHEX, the conference for biopharmaceutical engineering
Equilibar’s Ryan Heffner and Jeff Jennings recently returned from the INTERPHEX global conference in New York City. This was the first major conference Equilibar has participated in since COVID arrived in early 2020. INTERPHEX focuses on the biopharmaceutical market, which has been in the spotlight for the past two years as multiple vaccines and medications Read More